Levetiracetam (also known as levetiracetamum, levetiracetamum anhydricum, or S-enantiomer of etiracetam) is a white crystalline powder belonging to the pyrrolidone derivative class of antiepileptic drugs (AEDs). It is indicated as adjunctive therapy for partial-onset seizures in adult and pediatric patients aged 4 years and older. Administered orally, the dosage regimen must be individualized based on the patient's age, body weight, and renal function.

AccuSift provides high-performance competitive antibody pairs for levetiracetam detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.